NICOX (EPA:COX) | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
NICOX

BRIEF

published on 11/19/2024 at 07:35, 2 days 3 hours ago

Nicox Publishes Adaptive Design Results for NCX 470 Phase 3 Trial

Phase 3 Trial Nicox Glaucoma Treatment Clinical Results NCX 470
PRESS RELEASE

published on 11/19/2024 at 07:30, 2 days 3 hours ago

Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc Phase 3 Trial
Nicox announces the publication of the adaptive design period of the NCX 470 Mont Blanc Phase 3 trial, selecting 0.1% concentration due to better intraocular pressure reduction and safety profile

Phase 3 Trial Ophthalmology Nicox NCX 470 Adaptive Design
BRIEF

published on 10/14/2024 at 07:35, 1 month 7 days ago

Nicox and Soleus sign $16.5 million financing agreement

Funding Nicox NCX 470 Soleus Capital VYZULTA
PRESS RELEASE

published on 10/14/2024 at 07:30, 1 month 7 days ago

Nicox and Soleus Sign $16.5 million Royalty and Equity Financing
Nicox and Soleus sign $16.5 million royalty and equity financing agreement, reducing debt burden and financing into Q3 2025. Topline results expected in Q3 2025 for NCX 470 Denali Phase 3 trial

Equity Financing Nicox NCX 470 Soleus Royalty
BRIEF

published on 09/18/2024 at 07:35, 2 months 3 days ago

Nicox Announces Approval of ZERVIATE in China

China Ophthalmology Nicox ZERVIATE Ocumension
PRESS RELEASE

published on 09/18/2024 at 07:30, 2 months 3 days ago

Nicox Announces Approval of ZERVIATE in China
Nicox announces approval of ZERVIATE in China by partner Ocumension Therapeutics for ocular itching, adding royalty revenue stream. Launch expected to boost market penetration

China Approval Nicox ZERVIATE Ocular Itching
BRIEF

published on 09/04/2024 at 07:35, 2 months 17 days ago

Nicox Appoints Christine Placet as Director; Michele Garufi Retires from Board of Directors

Board Of Directors Ophthalmology Christine Placet Nicox Michele Garufi
PRESS RELEASE

published on 09/04/2024 at 07:30, 2 months 17 days ago

Nicox Appoints Christine Placet to Board of Directors; Michele Garufi steps down from Board
Nicox appoints Christine Placet to Board of Directors as Michele Garufi steps down after over 25 years. Entire Nicox Board renewed for strategic direction support

Board Of Directors Biotech Industry Christine Placet Nicox Michele Garufi
BRIEF

published on 07/19/2024 at 07:35, 4 months 2 days ago

Nicox: Participation in upcoming conferences

Conférences 2024 Investments Ophthalmology Nicox
PRESS RELEASE

published on 07/19/2024 at 07:30, 4 months 2 days ago

Nicox announces attendance at upcoming conferences
Nicox announces attendance at upcoming international conferences, including H.C. Wainwright 4th Annual Ophthalmology Virtual Conference and AAO 2024

Clinical Development International Conférences Ophthalmology Nicox

Accesswire

Published on 11/21/2024 at 10:03, 48 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 51 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 51 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 16 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 26 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 21 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 46 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 49 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 51 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 51 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 53 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 31 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 6 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 6 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE